Mounjaro is only FDA approved for Type 2 Diabetes, however Zepbound (also tirzepatide) is a new medication that is FDA approved for weight loss.
Unlike semaglutide (Wegovy/Ozempic), Mounjaro/Zepbound (tirzepetide) mimics 2 hormones in the body (not 1) to regulate blood sugar and decrease appetite.
According to the weight loss studies, Mounjaro/Zepbound (tirzepatide) results in slightly more weight loss over about a 1-year period compared to semaglutide (Wegovy/Ozempic).
Most insurance companies will only pay for Mounjaro for diabetics, and likely due to the cost of this medication, many insurance companies won’t approve Mounjaro for diabetics unless they have tried and failed cheaper alternatives. Zepbound is indicated for weight loss, however not all insurance companies cover Zepbound.
Side effects for Mounjaro/Zepbound (tirzepatide) are similar to semaglutide (Wegovy/Ozempic), and the diet plan for tirzepatide is similar to the one for semaglutide.
Tirzepatide is sold by some compounding pharmacies, though currently, it is a bit more difficult to find than semaglutide, and the cost is closer to $500 per month (almost twice as expensive as compounded semaglutide).
Contraindications to tirzepatide:
To request your appointment, please call (469) 414-9660 or contact us online today!
Pure Medicine
4645 Avon Lane, Suite 200
Frisco, TX 75033
Phone: (469) 414-9660